122151-38-6 | (S)-2-Hydroxy-1-(pyrrolidin-1-yl)propan-1-one

123-75-1    687-47-8    122151-38-6 

[1]Geist,Egor;Berneaud-Kötz,Helge;Baikstis,Tomas;Dräger,Gerald;Kirschning,Andreas[OrganicLetters,2019,vol.21,#22,p.8930-8933]

[2]Devine,PaulN.;Dolling,Ulf-H.;HeidJr.,RichardM.;Tschaen,DavidM.[TetrahedronLetters,1996,vol.37,#16,p.2683-2686]

[3]CurrentPatentAssignee:DIATEXINC-US2007/72858,2007,A1Locationinpatent:Page/Pagecolumn12

[4]CurrentPatentAssignee:CELLIXBIOPRIVATELTD-WO2013/167996,2013,A1Locationinpatent:Paragraph0094;0095

[5]CurrentPatentAssignee:CELLIXBIOPRIVATELTD-US9321716,2016,B1Locationinpatent:Page/Pagecolumn25-26;27

[6]Li,Fangzheng;Good,Steffen;Tulchinsky,MichaelL.;Whiteker,GregoryT.[OrganicProcessResearchandDevelopment,2019,vol.23,#10,p.2253-2260]

[7]Lu,Ping;Mailyan,Artur;Gu,Zhenhua;Guptill,DavidM.;Wang,Hengbin;Davies,HuwM.L.;Zakarian,Armen[JournaloftheAmericanChemicalSociety,2014,vol.136,#51,p.17738-17749]

[8]Locationinpatent:experimentalpartLewis,FrankW.;Eichler,MatthiasC.;Grayson,DavidH.[Synlett,2009,#12,p.1923-1928]

[9]Schurig,Volker;Betschinger,Frank[BulletindelaSocieteChimiquedeFrance,1994,vol.131,p.555-560]

[10]CurrentPatentAssignee:Syngenta(in:SinochemHoldings);SINOCHEMHOLDINGSCORPORATIONLTD-US2009/227453,2009,A1Locationinpatent:Page/Pagecolumn5-6

[11]Ammazzalorso,Alessandra;Amoroso,Rosa;Bettoni,Giancarlo;DeFilippis,Barbara;Fantacuzzi,Marialuigia;Giampietro,Letizia;Maccallini,Cristina;Tricca,MariaL.[EuropeanJournalofOrganicChemistry,2006,#18,p.4088-4091]

[12]Pellicena,Miquel;Solsona,JoanG.;Romea,Pedro;Urpi,Felix[Tetrahedron,2012,vol.68,#50,p.10338-10350,13]Pellicena,Miquel;Solsona,JoanG.;Romea,Pedro;Urpí,Fèlix[Tetrahedron,2012,vol.68,#50,p.10338-10350]

[13]Gómez-Palomino,Alejandro;Pellicena,Miquel;Krämer,Katrina;Romea,Pedro;Urpí,Fèlix;Aullón,Gabriel;Padrón,JoséM.[OrganicandBiomolecularChemistry,2017,vol.15,#8,p.1842-1862]

[14]Kock,Mario;Jones,PeterG.;Lindel,Thomas[OrganicLetters,2017,vol.19,#23,p.6296-6299]

109-97-7    687-47-8    122151-38-6 

[1]Ito;Kobayashi;Kawabata;Takase;Terashima[Tetrahedron,1989,vol.45,#18,p.5767-5790]

100-44-7    122151-38-6    122151-32-0 

[1]Ito;Kobayashi;Kawabata;Takase;Terashima[Tetrahedron,1989,vol.45,#18,p.5767-5790]

[2]Gómez-Palomino,Alejandro;Pellicena,Miquel;Krämer,Katrina;Romea,Pedro;Urpí,Fèlix;Aullón,Gabriel;Padrón,JoséM.[OrganicandBiomolecularChemistry,2017,vol.15,#8,p.1842-1862]

[3]Martin,Ricardo;Pascual,Oscar;Romea,Pedro;Rovira,Roser;Urpi,Felix;Vilarrasa,Jaume[TetrahedronLetters,1997,vol.38,#9,p.1633-1636]

[4]Geist,Egor;Berneaud-Kötz,Helge;Baikstis,Tomas;Dräger,Gerald;Kirschning,Andreas[OrganicLetters,2019,vol.21,#22,p.8930-8933]

[5]Ferrero;Galobardes;Martin;Montes;Romea;Rovira;Urpi;Vilarrasa[Synthesis,2000,#11,p.1608-1614]

[6]Pellicena,Miquel;Solsona,JoanG.;Romea,Pedro;Urpi,Felix[Tetrahedron,2012,vol.68,#50,p.10338-10350,13]Pellicena,Miquel;Solsona,JoanG.;Romea,Pedro;Urpí,Fèlix[Tetrahedron,2012,vol.68,#50,p.10338-10350]

[7]Li,Fangzheng;Good,Steffen;Tulchinsky,MichaelL.;Whiteker,GregoryT.[OrganicProcessResearchandDevelopment,2019,vol.23,#10,p.2253-2260]

123-75-1    27871-49-4    122151-38-6 

[1]CurrentPatentAssignee:CELLIXBIOPRIVATELTD-US9321716,2016,B1Locationinpatent:Page/Pagecolumn31-32;35

[2]Martin,Ricardo;Pascual,Oscar;Romea,Pedro;Rovira,Roser;Urpi,Felix;Vilarrasa,Jaume[TetrahedronLetters,1997,vol.38,#9,p.1633-1636]

[3]Ferrero;Galobardes;Martin;Montes;Romea;Rovira;Urpi;Vilarrasa[Synthesis,2000,#11,p.1608-1614]

[4]Lagu,Bharat;Wetzel,JohnM.;Forray,Carlos;Patane,MichaelA.;Bock,MarkG.[BioorganicandMedicinalChemistryLetters,2000,vol.10,#24,p.2705-2707]

[5]CurrentPatentAssignee:H.LUNDBECKA/S-US6727264,2004,B1Locationinpatent:Pagecolumn65;66;103;104

[6]CurrentPatentAssignee:METROCHEMAPIPVT-WO2019/77627,2019,A1Locationinpatent:Page/Pagecolumn12;14;15

[7]CurrentPatentAssignee:BRIGHTGENEBIOMEDICALTECHNOLOGYCOLTD-CN109824612,2019,ALocationinpatent:Paragraph0039;0040;0041;0042;0062;0064-0066

[8]CurrentPatentAssignee:BRIGHTGENEBIOMEDICALTECHNOLOGYCOLTD-CN109796446,2019,ALocationinpatent:Paragraph0043;0044;0045;0046;0072;0074;0075;0076

[9]CurrentPatentAssignee:BRIGHTGENEBIOMEDICALTECHNOLOGYCOLTD-CN109912461,2019,ALocationinpatent:Paragraph0040-0043;0065;0067-0068

122151-38-6    18162-48-6    188659-92-9 

[1]Martin,Ricardo;Pascual,Oscar;Romea,Pedro;Rovira,Roser;Urpi,Felix;Vilarrasa,Jaume[TetrahedronLetters,1997,vol.38,#9,p.1633-1636]

[2]Ferrero;Galobardes;Martin;Montes;Romea;Rovira;Urpi;Vilarrasa[Synthesis,2000,#11,p.1608-1614]

[3]Lagu,Bharat;Wetzel,JohnM.;Forray,Carlos;Patane,MichaelA.;Bock,MarkG.[BioorganicandMedicinalChemistryLetters,2000,vol.10,#24,p.2705-2707]

[4]CurrentPatentAssignee:H.LUNDBECKA/S-US6727264,2004,B1Locationinpatent:Pagecolumn65;66;103;104

[5]Locationinpatent:schemeortableEsteve,Judit;Jimenez,Carme;Nebot,Joaquim;Velasco,Javier;Romea,Pedro;Urpi,Flix[Tetrahedron,2011,vol.67,#33,p.6045-6056]